APOE and Alzheimer disease: With its primary source of expression being astrocytes, and to a lesser extent microglia and neurons, the APOE4 variant has been shown to disrupt physiological glial cell function, highlighting a potential mechanism by which astrocytes and microglia are involved in AD pathogenesis.